Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CCRN Stock Forecast 2025-2026
$12.37
Current Price
$405.27M
Market Cap
Buy 0
Hold 7
Sell 0
Wall St Analyst Ratings
Distance to CCRN Price Targets
+50.4%
To High Target of $18.61
+50.4%
To Median Target of $18.61
+50.4%
To Low Target of $18.61
CCRN Price Momentum
+0.9%
1 Week Change
+0.8%
1 Month Change
+19.4%
1 Year Change
-31.9%
Year-to-Date Change
-32.5%
From 52W High of $18.33
+29.1%
From 52W Low of $9.58
📊 TOP ANALYST CALLS
Did CCRN Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cross Country is one of their latest high-conviction picks.
Latest CCRN Stock Price Targets & Analyst Predictions
Based on our analysis of 14 Wall Street analysts, CCRN has a neutral consensus with a median price target of $18.61 (ranging from $18.61 to $18.61). The overall analyst rating is N/A (N/A/10). Currently trading at $12.37, the median forecast implies a 50.4% upside. This outlook is supported by 0 Buy, 7 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Kevin Steinke at Barrington Research, projecting a 50.4% upside. Conversely, the most conservative target is provided by Kevin Steinke at Barrington Research, suggesting a 50.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CCRN Analyst Ratings
0
Buy
7
Hold
0
Sell
CCRN Price Target Range
Low
$18.61
Average
$18.61
High
$18.61
Current: $12.37
Latest CCRN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CCRN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 17, 2025 | Barrington Research | Kevin Steinke | Market Perform | Maintains | $18.61 |
| May 13, 2025 | UBS | A.J. Rice | Neutral | Maintains | $16.50 |
| Mar 14, 2025 | Barrington Research | Kevin Steinke | Market Perform | Maintains | $18.61 |
| Feb 6, 2025 | JMP Securities | Constantine Davides | Market Perform | Reiterates | $N/A |
| Dec 10, 2024 | Barrington Research | Kevin Steinke | Market Perform | Downgrade | $N/A |
| Dec 5, 2024 | Truist Securities | Tobey Sommer | Hold | Maintains | $18.61 |
| Nov 7, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $18.00 |
| Oct 21, 2024 | Truist Securities | Tobey Sommer | Hold | Maintains | $15.00 |
| Aug 8, 2024 | Barrington Research | Kevin Steinke | Outperform | Maintains | $19.00 |
| Aug 1, 2024 | Truist Securities | Tobey Sommer | Hold | Maintains | $17.00 |
| May 6, 2024 | Barrington Research | Kevin Steinke | Outperform | Maintains | $21.00 |
| May 2, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $19.00 |
| Feb 27, 2024 | Barrington Research | Kevin Steinke | Outperform | Maintains | $24.00 |
| Feb 22, 2024 | Truist Securities | Tobey Sommer | Hold | Maintains | $16.00 |
| Feb 22, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $21.00 |
| Dec 6, 2023 | JMP Securities | Constantine Davides | Market Perform | Initiates | $N/A |
| Nov 30, 2023 | UBS | A.J. Rice | Neutral | Initiates | $22.00 |
| Nov 29, 2023 | Barrington Research | Kevin Steinke | Outperform | Maintains | $26.00 |
| Nov 3, 2023 | Truist Securities | Tobey Sommer | Hold | Maintains | $22.00 |
| Nov 3, 2023 | Jefferies | Brian Tanquilut | Hold | Downgrade | $21.00 |
Cross Country Healthcare Inc. (CCRN) Competitors
The following stocks are similar to Cross Country based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cross Country Healthcare Inc. (CCRN) Financial Data
Cross Country Healthcare Inc. has a market capitalization of $405.27M with a P/E ratio of 48.3x. The company generates $1.19B in trailing twelve-month revenue with a -0.7% profit margin.
Revenue growth is -19.3% quarter-over-quarter, while maintaining an operating margin of +0.7% and return on equity of -2.0%.
Valuation Metrics
Market Cap
$405.27M
Enterprise Value
$348.79M
P/E Ratio
48.3x
PEG Ratio
-0.8x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
-19.3%
Gross Margin
+20.4%
Operating Margin
+0.7%
Net Margin
-0.7%
EPS Growth
-19.3%
Financial Health
Cash/Price Ratio
+20.0%
Current Ratio
3.2x
Debt/Equity
0.7x
ROE
-2.0%
ROA
+0.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cross Country Healthcare Inc. (CCRN) Business Model
About Cross Country Healthcare Inc.
What They Do
Provides staffing solutions for the healthcare sector.
Business Model
The company generates revenue by offering a variety of staffing services, including travel nurse and allied health staffing, per diem and permanent placements, and workforce management solutions. By partnering with healthcare facilities, it helps them maintain optimal staffing levels, which is essential for quality patient care.
Additional Information
Established in Boca Raton, Florida, Cross Country Healthcare has a significant presence in nursing, emergency medicine, and allied health sectors. The company's extensive industry expertise and network enable it to effectively address staffing shortages and improve healthcare accessibility across the United States.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
9,605
CEO
Mr. John A. Martins
Country
United States
IPO Year
2001
Website
www.crosscountry.comCross Country Healthcare Inc. (CCRN) Latest News & Analysis
Latest News
Quick Summary
Cross Country's marketing team has been recognized as the No. 1 Marketing Team in the Nation by the 2025 OnCon Icon Awards.
Why It Matters
Cross Country's marketing team recognition boosts brand reputation, potentially increasing customer trust and sales, which can lead to higher stock performance and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Investors in Staffing Firms should consider Kelly Services (KELYA) and Cross Country Healthcare (CCRN) as potential undervalued stock options.
Why It Matters
The comparison of Kelly Services and Cross Country Healthcare highlights potential undervaluation, guiding investors towards better investment opportunities in staffing firms.
Source: Zacks Investment Research
Market Sentiment:
Positive
New Strong Sell Stocks for October 1st
1 month ago
Quick Summary
AGL, PLAY, and CCRN were added to the Zacks Rank #5 (Strong Sell) List on October 1, 2025, indicating a negative outlook for these stocks.
Why It Matters
AGL, PLAY, and CCRN being added to the Zacks Rank #5 indicates a negative outlook, suggesting potential declines in stock performance and higher risk for investors.
Source: Zacks Investment Research
Market Sentiment:
Negative
New Strong Sell Stocks for August 20th
2 months ago
Quick Summary
AGL, CCRN, and GOGL have been assigned a Zacks Rank of #5 (Strong Sell) as of August 20, 2025.
Why It Matters
AGL, CCRN, and GOGL receiving a Zacks Rank #5 signals potential underperformance, indicating higher risk for investors and prompting reassessment of investment positions.
Source: Zacks Investment Research
Market Sentiment:
Negative
CCRN Earnings Drop 19%
3 months ago
Quick Summary
Cross Country Healthcare (CCRN) missed expectations for GAAP revenue and non-GAAP EPS in its Q2 results reported on August 6, 2025.
Why It Matters
Cross Country Healthcare's significant revenue and EPS miss signals potential operational challenges, which may negatively affect stock performance and investor confidence.
Source: The Motley Fool
Market Sentiment:
Neutral
Quick Summary
Cross Country Healthcare (Nasdaq: CCRN) reported Q2 2025 revenue of $274.1M, down 19% YoY and 7% QoQ. Gross profit margin at 20.4%. Net loss was $6.7M, a 59% decrease YoY.
Why It Matters
Cross Country Healthcare's Q2 2025 revenue and net loss show significant declines, indicating potential financial instability and challenges in profitability, which could affect investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About CCRN Stock
What is Cross Country Healthcare Inc.'s (CCRN) stock forecast for 2026?
Based on our analysis of 14 Wall Street analysts, Cross Country Healthcare Inc. (CCRN) has a median price target of $18.61. The highest price target is $18.61 and the lowest is $18.61.
Is CCRN stock a good investment in 2026?
According to current analyst ratings, CCRN has 0 Buy ratings, 7 Hold ratings, and 0 Sell ratings. The stock is currently trading at $12.37. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CCRN stock?
Wall Street analysts predict CCRN stock could reach $18.61 in the next 12 months. This represents a 50.4% increase from the current price of $12.37. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cross Country Healthcare Inc.'s business model?
The company generates revenue by offering a variety of staffing services, including travel nurse and allied health staffing, per diem and permanent placements, and workforce management solutions. By partnering with healthcare facilities, it helps them maintain optimal staffing levels, which is essential for quality patient care.
What is the highest forecasted price for CCRN Cross Country Healthcare Inc.?
The highest price target for CCRN is $18.61 from Kevin Steinke at Barrington Research, which represents a 50.4% increase from the current price of $12.37.
What is the lowest forecasted price for CCRN Cross Country Healthcare Inc.?
The lowest price target for CCRN is $18.61 from Kevin Steinke at Barrington Research, which represents a 50.4% increase from the current price of $12.37.
What is the overall CCRN consensus from analysts for Cross Country Healthcare Inc.?
The overall analyst consensus for CCRN is neutral. Out of 14 Wall Street analysts, 0 rate it as Buy, 7 as Hold, and 0 as Sell, with a median price target of $18.61.
How accurate are CCRN stock price projections?
Stock price projections, including those for Cross Country Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 9, 2025 10:38 AM UTC